Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke
Clinical trial NCT07483281 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07483281
- Sponsor
- China-Japan Union Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-03-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.